Infertility

Charles River to Perform Plasmid Production for Ship of Theseus

Retrieved on: 
Thursday, April 4, 2024
Health, Medical Devices, Stem Cells, Genetics, General Health, Pharmaceutical, Biotechnology, Diabetes, Neutropenia, CDMO, Psoriasis, Infertility, Cancer, MCB, Tissue, CRL, DNA, Research, Pattern hair loss, HOX, Ship, Acquisition, Factorization of polynomials, Display resolution, GMP, Good manufacturing practice, Tecmar, Therapy, HQ, Vaccine

Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.
  • Ship of Theseus will leverage Charles River’s premier expertise to manufacture GMP plasmid DNA to serve as the active drug substance for its lead candidate.
  • Charles River’s GMP plasmid DNA CDMO center of excellence based in Keele, United Kingdom will lead the collaboration, providing services that include plasmid DNA backbone generation, plasmid synthesis, GMP master cell bank (MCB) generation, pre-production evaluation, and GMP plasmid DNA manufacture including in-house release testing.
  • We trust the team’s decades of success developing, producing, and reliably delivering plasmid DNA and look forward to bringing our therapies to patients.” – Jeremy Elser, Founding CEO, Ship of Theseus

Prudential Financial introduces new workplace insurance benefits that help support mental health and growing families

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Mental Health, Health, Insurance, Health Insurance, Human Resources, Finance, PRU, Substance abuse, Infertility, Prudential Financial, Prudential, Mental health, Prenatal care, Hospice and palliative medicine, Anxiety, DSM-IV codes, Hospital, Multimedia, Family, Group insurance, Health insurance

Prudential Financial, Inc. ( NYSE: PRU ) has introduced new voluntary workplace insurance offerings that help support family building and mental health, including benefits that cover fertility procedures, extended hospital stays, screenings for substance use, and severe mental illness.

Key Points: 
  • Prudential Financial, Inc. ( NYSE: PRU ) has introduced new voluntary workplace insurance offerings that help support family building and mental health, including benefits that cover fertility procedures, extended hospital stays, screenings for substance use, and severe mental illness.
  • View the full release here: https://www.businesswire.com/news/home/20240404432800/en/
    Jess Gillespie, Head of Product and Underwriting, Prudential Group Insurance (Photo: Business Wire)
    Voluntary or supplemental insurance refers to optional, employee-paid benefits that can help pay for out-of-pocket medical expenses not covered by health insurance, such as co-pays, co-insurance and deductibles.
  • As part of Prudential Group Insurance’s expanded suite of Critical Illness and Hospital Indemnity insurance, the new mental health benefits include screenings for anxiety, mood disorders and substance abuse — as well as coverage for the most diagnosed mental health conditions and severe mental illness.
  • “Employees turn to their employers for benefits that can help them during key life events,” said Gillespie.

CBIZ’s 2024 State of Health Care Report Highlights Areas of Priority for Employer Benefit Plan Sponsors

Retrieved on: 
Tuesday, April 2, 2024
Consulting, Professional Services, Managed Care, Health, General Health, Small Business, Health Insurance, Genetics, Insurance, Human Resources, Finance, Steps, Element, Diagnosis, CBZ, Organization, Family, Infertility, Talent, Communication, Health insurance

CBIZ (NYSE: CBZ), a leading national provider of insurance, financial and advisory services, released its second annual State of Health Care Report.

Key Points: 
  • CBIZ (NYSE: CBZ), a leading national provider of insurance, financial and advisory services, released its second annual State of Health Care Report.
  • The State of Health Care Report includes responses from 338 businesses, spanning more than 27 states, the majority of which have more than 100 employees.
  • The survey provides insight into employer priorities, top health plan features, and emerging mental and physical health benefit trends to watch through the remainder of 2024.
  • “The insights from our State of Health Care Report reinforce the critical link between comprehensive benefits, effective communication, and strategic cost control.

Navigating Birth Control: Expert Advice from Dr. Bana Kashani, OB-GYN

Retrieved on: 
Friday, March 29, 2024
Women, Other Communications, Baby, Maternity, Communications, Practice Management, Family, Health, Consumer, General Health, Birth, Pregnancy, Infertility, Q&A, Intrauterine device, Condom, Menstrual cycle, Sterilization, IUD, Ovulation, Research, Fertility, Pelvic inflammatory disease, Hormonal contraception, Tubing (recreation), STI, Woman, USB On-The-Go, Birth control

In a rapidly evolving landscape of reproductive health, navigating the variety of birth control options can be overwhelming.

Key Points: 
  • In a rapidly evolving landscape of reproductive health, navigating the variety of birth control options can be overwhelming.
  • “When choosing a birth control method, it's essential to consider factors such as efficacy, convenience, side effects, and personal preferences.
  • Dr. Kashani sheds light on various birth control methods in the following Q&A:
    What are the different types of birth control methods available?
  • There is limited evidence to suggest that using birth control methods for an extended period negatively impacts fertility.

China In-Vitro Fertilization Market Research Report 2023-2030 Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
General Health, Other Health, Consumer, Health, Baby, Maternity, Consciousness, Infertility, Prevalence, IVF, Sterilization, Fertility, Fertilisation, Woman, Male, Infection, Patient safety, ICSI, Birth control

Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.

Key Points: 
  • Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.
  • Disposable devices are predicted to be among the instruments used considerably in the China In-Vitro Fertilization (IVF) market.
  • ICSI IVF is foreseen to be among the considerably utilized processes in the China In-Vitro Fertilization (IVF) market.
  • Fertility clinics are projected to experience a considerable increase in utilization in the China In-Vitro Fertilization (IVF) market.

Ivy Fertility Hires Dr. Bryn Willson and Dr. Shelun Tsai

Retrieved on: 
Thursday, March 21, 2024
Baby, Maternity, Managed Care, Other Health, Health, Women, Other Science, Research, Hospitals, Genetics, Consumer, Science, Cedars-Sinai Medical Center, Education, Weill Cornell Medicine, SDFC, Patient, Duke University, UC, University, Weill Cornell Medical Center, MD, Pacific coast, Infertility, Gynaecology, Harvard University, University of California, Davis, Santa Clara University, Golden apple, Obstetrics, Duke, Physician, Hedera

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.
  • Dr. Willson and Dr. Tsai are both board-certified in obstetrics and gynecology, and will complete their fellowships in reproductive endocrinology this spring.
  • “The entire Ivy Fertility network is committed to staying at the forefront of fertility science,” said Sandy Chuan, MD, Medical Director at San Diego Fertility Center.
  • “We are privileged that Dr. Willson and Dr. Tsai will be contributing their innovation and compassion to our network.”

Merck Foundation CEO, Senator Dr. Rasha Kelej Awarded on International Women’s Day for Her Efforts Towards Women Empowerment and Supporting Girl Education

Retrieved on: 
Friday, March 15, 2024
Other Education, University, Practice Management, Education, Business, Training, Professional Services, General Health, Philanthropy, Women, Children, Foundation, Other Philanthropy, Consumer, Health, Communication, Infertility, Woman, International, Art, Ministry, Social, Multimedia, Movement, Ambassador, Pharmaceutical industry

On the occasion of International Women’s Day, Business Executive Group awarded Senator Dr. Rasha Kelej, CEO of Merck Foundation , at their Global She Achievers Awards 2024, for her efforts to empower women in STEM, and girls in education, and building healthcare capacity in Africa and beyond.

Key Points: 
  • On the occasion of International Women’s Day, Business Executive Group awarded Senator Dr. Rasha Kelej, CEO of Merck Foundation , at their Global She Achievers Awards 2024, for her efforts to empower women in STEM, and girls in education, and building healthcare capacity in Africa and beyond.
  • View the full release here: https://www.businesswire.com/news/home/20240315990515/en/
    Senator Dr. Rasha Kelej, CEO of Merck Foundation (Photo: Business Wire)
    Senator Dr. Rasha Kelej, CEO of Merck Foundation expressed gratitude, remarking, "Firstly, Happy International Women’s Day to all the women in the world and to the men who support and empower them.
  • "It is a great honor to receive The Global She Achievers Award 2024, that too on the very important occasion of International Women’s Day.
  • Merck Foundation is contributing to building and advancing fertility care capacity in Africa and Asia, to support childless women and couples.

Reproductive Medicine Associates Opens New State-of-the-Art Fertility Center and IVF Lab in Bellevue, Expanding Access to Fertility Care in Washington State

Retrieved on: 
Wednesday, March 13, 2024
Science, Practice Management, Research, Managed Care, General Health, Health, Hospitals, Other Health, Seattle metropolitan area, Infertility, FACOG, Patient, IVF, Interstate 405, Reproductive medicine, Fertility, IUI, MD, IVI, RMA, Medical director, Interstate Highway System, PGT, MSCE, Birth control

Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, announced the opening of its new state-of-the-art fertility center and in vitro fertilization lab (IVF) in Bellevue.

Key Points: 
  • Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, announced the opening of its new state-of-the-art fertility center and in vitro fertilization lab (IVF) in Bellevue.
  • The clinic is RMA’s second location in Washington state, after Seattle, and adds to an extensive network of more than sixty RMA clinics across the United States.
  • “We’re committed to expanding access to cutting-edge fertility care for the roughly 1 in 5 Americans who struggle with infertility,” said Lynn Mason, CEO of IVI RMA America.
  • The center will also offer family planning resources and options for LGBTQ+ individuals and fertility preservation treatments for those individuals with autoimmune diseases or cancer diagnoses.

Coast Guard Mutual Assistance (CGMA) and WIN Join Forces to Support Coast Guard Families in Their Family-Building Journey

Retrieved on: 
Wednesday, April 3, 2024
TRICARE, RET, Infertility, Partnership, WIN, Female, Fertility, Coast guard, Woman, USCG, CGMA, Coast Guard Mutual Assistance, Family, Birth control

GREENWICH, Conn., April 3, 2024 /PRNewswire/ -- WIN, the nation's leading family-building and family well-being benefit company, is proud to announce its collaboration with Coast Guard Mutual Assistance (CGMA) to provide comprehensive fertility benefit management services for Coast Guard members. The donated services offered include 24/7 clinical guidance through WIN Nurse Care Advocates, reproductive behavioral support, access to the WIN highly credentialed qualified network of medical and pharmacy providers and on-demand clinical support and resources through the WINFamily app—wherever their duties take them, along with available discounts, and guided counseling on family-building options.

Key Points: 
  • The CGMA-WIN initiative seeks to address these challenges by offering comprehensive support tailored to the needs of Coast Guard service members and their families.
  • "We understand the challenges that military families face and are committed to supporting Coast Guard members on their journey to parenthood.
  • Through this partnership, we aim to provide comprehensive and accessible resources that empower Coast Guard families to build their families."
  • "We are thrilled to offer WIN's support to our Coast Guard community's family-building aspirations," said RADM Cari B. Thomas, USCG (Ret), CEO of Coast Guard Mutual Assistance.

Family Source Consultants Celebrates Michigan Legislature Passing Landmark Fertility Health Care Act (House Bill 5207) to Legalize Surrogacy Arrangements

Retrieved on: 
Wednesday, March 27, 2024
Michigan Legislature, Infertility, Child, Fertility, Family, Organization, House, Woman, Heart, Consultant, Dream, Reproductive rights, Parent, Legislation, Birth control

CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Family Source Consultants Celebrates Michigan Legislature Passing Landmark Fertility Health Care Act (House Bill 5207) to Legalize Surrogacy Arrangements.

Key Points: 
  • CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Family Source Consultants Celebrates Michigan Legislature Passing Landmark Fertility Health Care Act (House Bill 5207) to Legalize Surrogacy Arrangements.
  • Family Source Consultants, a leading third-party reproduction agency that specializes in matching and facilitating surrogacy and egg donation arrangements, praises the Michigan Legislature for taking a historic step forward in reproductive rights by passing the Fertility Health Care Act ( House Bill 5207 ).
  • This groundbreaking legislation legalizes and regulates surrogacy arrangements in the state of Michigan providing transparency and protection for all parties involved in a surrogacy arrangement.
  • By providing a legal framework for surrogacy, the Fertility Health Care Act aims to promote fairness, transparency, and ethical practices within the surrogacy process.